Protocol Lab for Online Trials-Delphi (PLOT-D)

March 19, 2021 updated by: ThinkWell

Protocol Lab for Online Trials-Delphi (PLOT-D)

The Protocol Lab for Online Trials-Delphi (PLOT-D) module will use an online three-round Delphi combined with Participatory action research to inform the development of a multi-use protocol template to use in writing protocols for self-recruited online trials of interventional self-management. The Delphi will include an embedded randomized controlled trial to test how and if stakeholders adapt their views based on the contributions of others inside or outside the groups with which they are familiar.

Study Overview

Detailed Description

The research aims to provide support for citizens to work alongside researchers to build participatory health trials online (any randomized trial that uses the internet for a health or wellness intervention). Tools to develop methods to run quality online trials protocols are needed. Also, help for adapting guidance to include the public and patients as partners in research for online trials is limited. The purpose of this work is to facilitate improved practice within protocol writing for participatory online trials.

Public and patient involvement (PPI), is one method used to conduct participatory research. PPI actively engages communities or individuals and moves beyond educating, engaging or doing interviews with research participants and does the research with them as partners. There is growing consensus that PPI is of value to researchers, industry, regulators, and members of the public.

There is an active discussion that is without substantial evidence for when the optimal time in the research process is to start PPI and whether patients and the public should join the research team, act as advisors, or have everyone contribute perspectives and work with their roles or peer groups.

The embedded study within the Delphi explores how working with stakeholder feedback in different ways may influence decision ranking as well choice similarities and differences

Study Type

Interventional

Enrollment (Actual)

385

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX4 4DN
        • ThinkWell

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Protocol lab for online trials Delphi (PLOT-D) participants

Exclusion Criteria:

  • None if inclusion criteria are met

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Integrative
Stakeholder groups: a-b
ACTIVE_COMPARATOR: Role Specific
Stakeholder groups: a or b
ACTIVE_COMPARATOR: Consecutive
Stakeholder groups: a=> b

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The top five disparities and similarities in ranking between interventions
Time Frame: Up to 20 weeks or study completion
Prioritization of method preferences as decided by participants
Up to 20 weeks or study completion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences and similarities between stakeholder groups
Time Frame: Up to 20 weeks or study completion
Ranking differences between stakeholders randomized to different forms of information presentation
Up to 20 weeks or study completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Amy I Price, PhD, University of Oxford
  • Principal Investigator: Mike J Clarke, DPhil, Queen's University, Belfast

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 15, 2019

Primary Completion (ACTUAL)

May 15, 2019

Study Completion (ACTUAL)

October 30, 2019

Study Registration Dates

First Submitted

April 1, 2018

First Submitted That Met QC Criteria

April 7, 2018

First Posted (ACTUAL)

April 17, 2018

Study Record Updates

Last Update Posted (ACTUAL)

March 23, 2021

Last Update Submitted That Met QC Criteria

March 19, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • PLOT-D Ranking

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Aggregated de-identified data will be available on request to principal investigator Amy Price dr.amyprice@gmail.com

IPD Sharing Time Frame

following publication and for 5 years

IPD Sharing Access Criteria

email investigator dr.amyprice@gmail.com

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Decisional Variability by Presentation Methods for Consensus

Clinical Trials on Integrative

3
Subscribe